CN1209115C - Active extracted composition of teasel root and notoginseng and use in medicine - Google Patents
Active extracted composition of teasel root and notoginseng and use in medicine Download PDFInfo
- Publication number
- CN1209115C CN1209115C CN 03112869 CN03112869A CN1209115C CN 1209115 C CN1209115 C CN 1209115C CN 03112869 CN03112869 CN 03112869 CN 03112869 A CN03112869 A CN 03112869A CN 1209115 C CN1209115 C CN 1209115C
- Authority
- CN
- China
- Prior art keywords
- medicine
- notoginseng
- radix notoginseng
- radix
- teasel root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an active extracted composition of teasel root and notoginseng and the application to the preparation of the medicine for curing fracture and osteoporosis, which is developed by utilizing a modern medicine theory on the basis of a conventional traditional Chinese medicine theory and has the advantages of simple prescription, specific effective component, outstanding curative effect and controllable quality. The active extracted composition of teasel root and notoginseng is composed of teasel root total saponins and notoginseng total saponins with the weight ratio of 1: 0.2 to 15, and the optimum weight ratio of the teasel root total saponins to the notoginseng total saponins is 1: 0.5 to 5.
Description
Technical field:
The present invention relates to the active extract composition of a kind of Radix Dipsaci and Radix Notoginseng and pharmaceutically using.This extraction compositions is respectively on-off total saponin as well as and Radix Notoginseng total arasaponins.Said composition can be used for making treatment fracture and osteoporotic medicine.
Background technology:
Fracture is common damage, and old people and postmenopausal women be because the rapid minimizing of whole body bone amount, and the fragility of bone increases after the osteoporosis, and microtrauma can be fractured.The American scholar report postmenopausal women about 1/3～1/2 fracture because of osteoporosis, and the annual fracture that takes place is about 1,300,000 people, annual therefore expensive about 10,000,000,000 dollars.The fracture incidence rate that the Shanghai scholar reports 10429 old peoples more than 60 years old is 15.6%.And because healing is poor, complication is many, usually threat to life behind the senile fracture.Doctor trained in Western medicine does not still have obvious catagmatic medicine at present to the treatment of fractures reduction of the fracture commonly used and fracture fixation method.
Aspect bone healing, China's tradition Chinese medicine often adopts blood circulation promoting and blood stasis dispelling, and reducing swelling and alleviating pain is mended the bone bone strengthening, and the method for treatment of promoting tissue regeneration by removing blood stasis has original benefit, for doctor trained in Western medicine institute can not reach.Tradition Chinese patent medicine such as notoginseng injury tablet, powder for fracture and trauma, YUNNAN BAIYAO, Anisodus carniolicoides C.Y.Wu et C.Chen, pill for traumatic injuries, Yuzhen San, SANHUANG Apis cerana Fabricius ball, tiger bone-papaya wine, damage medicated wine etc., owing to comprise tens flavors at least in these medicaments, at most tens the flavor medical materials, the quality standard that most of neither ones are controlled, in a large amount of clinical case treatments, be difficult to obtain satisfied curative effect, also can partly leave over bone injury sequela sometimes.Therefore on the basis of traditional Chinese medicine theory, utilization modern medicine theory is developed a kind of determined curative effect, and quality controllable orthopedics department medication is significant.
Osteoporosis be a kind of with the bone amount reduce, the osseous tissue microstructure is unusual and fracture risk increases to a class disease of feature, is common in particularly postmenopausal women of old people, its sickness rate height, harm is big.At present, the treatment doctor trained in Western medicine of this disease mainly with estrogen, calcium preparation, calcitonin, Diphosphonate and fluoride preparation etc., because existing, these medicines is cost an arm and a leg reason such as the life-time service medication is dissatisfied, and side effect is big.Therefore, people turn to sight Chinese medicine in the excavation and research aspect the treatment osteoporosis gradually.
Summary of the invention:
The objective of the invention is to overcome the deficiency of above-mentioned Western medicine prior art and existing Chinese patent medicine, on the basis of traditional Chinese medicine theory, utilization modern medicine theory, developing a kind of prescription simplifies, effective ingredient is clear and definite, determined curative effect, quality controllable Radix Dipsaci and the active extract composition of Radix Notoginseng.
Another object of the present invention is to said composition and can be used for making the application for the treatment of in fracture and the osteoporotic medicine.
Purpose of the present invention can reach by following measure:
The present invention is made up of the activity extract of Radix Dipsaci and Radix Notoginseng.Exactly be made up of on-off total saponin as well as and Radix Notoginseng total arasaponins, its weight ratio is 1: 0.2～15, and its optimum weight ratio is 1: 0.5～5.
Radix Dipsaci is a Dipsacaceae plant Radix Dipsaci Dipsacus asperoides C.Y.Cheng et T.M.Ai dry root.The tool invigorating the liver and kidney, bone and muscle strengthening, continuous folding is hindered, and ends the effect of metrorrhagia.Be used for soreness of the waist and knees, rheumatic arthralgia, diseases such as injury from falling down.The total Saponin of Radix Dipsaci is the active component that Radix Dipsaci promotes bone injury healing effect.Radix Notoginseng is the dry root of panax araliaceae plant Panax notoginseng (Burk.) F.H.Chen.The hemostasis of tool dissipating blood stasis, the effect of subduing swelling and relieving pain.Be used for spitting of blood, spit blood epistaxis, traumatic hemorrhage, diseases such as tumbling and swelling.Radix Notoginseng is the incised wound key medicine, is commonly used for the monarch drug of injury from falling down medicine, and single, and compound recipe all can be used as medicine, and as Radix Notoginseng Tabellae, Radix Notoginseng total glucosides tablet, notoginseng injury tablet, pill for traumatic injuries etc. all are monarch drug with the Radix Notoginseng.Its effective ingredient is a Radix Notoginseng total arasaponins.As seen by above-mentioned, Radix Dipsaci is longer than invigorating the kidney and strengthening the bones, and Radix Notoginseng is longer than the dissipating blood stasis for subsidence of swelling analgesic therapy, and two medicines share, particularly two the effective elements of the medicines share, and can reach blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, the effect of mending the bone bone strengthening, and this prescription is simplified, and effective ingredient is clear and definite, the deficiency of complementary single medicinal material.
The present invention has the bone of benefit bone strengthening, and the effect of continuous folding wound can be used for making treatment fracture and osteoporotic medicine.
Pharmacodynamic study of the present invention is as follows:
1. to the effect of rat test treatment of fractures
24 of SD rats, male and female half and half are divided into 3 groups at random by the sex body weight, 8 every group.Be respectively blank group, positive drug control group (JIEGU QILI PIAN group), this medicine group.Cause wide 2mm every rat tibia, the damaged model of bone of dark 1mm.Rose in the 2nd day, every day gastric infusion, wherein, positive control pharmaceutical quantities 0.65g/kg, this medicine group 0.46g/kg, continuous 15 days, 24 hours sacrificed by decapitation were separated each tibia after the last administration, surveyed its former damaged place bone girth; And put into 4% formalin fixing after, the nitric acid ethanol decalcification with 7% is after 24 hours, in the rip cutting embedding of the damaged place of bone, the analysis of cutting into slices the results are shown in down:
The girth at the damaged place of tibia of each treated animal of table 1. (n=6, X ± SD, mm)
| Group | Dosage (g/kg) | Girth |
| Blank | 8.78±0.41 | |
| Positive control | 0.65 | 10.50±1.59 |
| This medicine group | 0.46 | 19.13±1.89* |
Annotate: * P＜0.01, with blank group ratio.
The pathology section examination result at the damaged place of tibia of each treated animal of table 2.
| Group | Blank | Positive control | This medicine group |
| Example number naked eyes indenture is observed fusiformis swelling poroma formation enchondral ossification mirror bone trabecula abundance area of new bone line parallel bone trabecula and is examined back shape trabecular bone mother cell interfibrillar substance | 5 1/5 0 + - + + + - + + | 5 3/5 0 + - ++ - + - + + | 6 4/6 2/6 +++ ++ ++ +++ - ++ +++ +++ |
As can be seen from the results, this medicine can make the callus at the damaged place of bone obviously thicken, and the bone girth increases, and illustrates that this medicine can promote the fracture osteogenesis; Further confirm the effect of this medicine from the tissue slice microscopy, it makes fracture present active bone skeletonization or enchondral ossification, and the osteoblast hypertrophy is very active, fibrosis callus bulge occurs, and this and blank and positive drug group relatively have tangible difference.
2. to the effect of rabbit experiment treatment of fractures
10 of rabbit are divided into 2 groups at random, are respectively blank group, this medicine group.1/3 place causes the standard fracture mouth that 3mm is wide, 2mm is dark under every rabbit radius.The hands second day after operation rises, CMC-Na 2ml/kg and this medicine 60mg/2ml/1kg of difference ig 0.5%, continuous 25 days.Put to death rabbit, separate each radius, survey the girth of its fracture, and measure its bone density, the results are shown in following table with the DEXA borne densitometers.
The girth at the damaged place of radius of two groups of rabbit of table 3. (n=5, X ± SD, mm)
| Group | Dosage (mg/kg) | Girth |
| This medicine of blank group | 60 | 18.0±1.1 22.1±0.8 * |
Annotate: * P＜0.01, with blank group ratio.
Bone density value (n=5, X ± SD, the g/cm at the damaged place of radius of two groups of rabbit of table 4.
2)
| Group | Dosage (mg/kg) | Girth |
| This medicine of blank group | 60 | 0.295±0.042 0.412±0.034 * |
Annotate: * P＜0.01, with blank group ratio.
The result shows that the girth at the damaged place of radius of this medicine group illustrates that apparently higher than matched group it can promote the formation of fracture callus; Simultaneously, apparently higher than matched group, further illustrate the effect of the short knitting of medicine as an objective indicator bone density value that reflects union of fracture.In addition, it is to cause osteoporotic direct and The key factor that the bone amount reduces, and this medicine is bone density improving significantly, illustrates that this medicine also has function of resisting osteoporosis.
The specific embodiment:
Embodiment 1:
The preparation of on-off total saponin as well as: get Radix Dipsaci decoction pieces 600g, add 80% ethanol of 7 times of medical material weight, reflux, extract, 3 times, extract 2 respectively, 2,1 hour, filter, merge extractive liquid, reclaims ethanol to there not being alcohol, and be condensed into the aqueous solution of 1g crude drug/ml, through ethyl acetate, water-saturated n-butanol respectively extracts 3 times, and the reclaim under reduced pressure n-butyl alcohol is done near, adds the small amount of methanol dissolving, in methanol solution, add ethyl acetate again, separate out precipitation, filter, get precipitation, dry, pulverize, cross 55 mesh sieves, promptly get the yellow on-off total saponin as well as finished product of ancestor, weight is 29.5g, and on-off total saponin as well as content is 52.2%.
Embodiment 2:
The preparation of Radix Notoginseng total arasaponins: get pseudo-ginseng and be ground into coarse powder 300g, add 70% ethanol of 8 times of medical material weight, reflux, extract, 3 times, extract 2 respectively, 2,1 hour, filter, merge extractive liquid, reclaims ethanol to there not being alcohol, and be condensed into the aqueous solution of 1g crude drug/ml, through ethyl acetate, water-saturated n-butanol respectively extracts 3 times, and the reclaim under reduced pressure n-butyl alcohol is done near, adds the small amount of methanol dissolving, in methanol solution, add ethyl acetate again, separate out precipitation, filter, get precipitation, dry, pulverize, cross 55 mesh sieves, promptly get the yellow Radix Notoginseng total arasaponins finished product of shallow ancestor, weight is 8.5g, and content of the total saponins in radix notoginseng is 54.5%.
Embodiment 3:
Close decoction and prepare on-off total saponin as well as and Radix Notoginseng total arasaponins: get Radix Dipsaci decoction pieces 600g and pseudo-ginseng coarse powder 300g and mix, 80% ethanol that adds 8 times of medical material weight, reflux, extract, 3 times, extract 2 respectively, 2,1 hour, filter, merge extractive liquid, reclaims ethanol to there not being alcohol, and be condensed into the aqueous solution of 1g crude drug/ml, through ethyl acetate, water-saturated n-butanol respectively extracts 3 times, and the reclaim under reduced pressure n-butyl alcohol is done near, adds the small amount of methanol dissolving, in methanol solution, add ethyl acetate again, separate out precipitation, filter, get precipitation, dry, pulverize, cross 55 mesh sieves, promptly get the mixture finished product of khaki on-off total saponin as well as and Radix Notoginseng total arasaponins, weight is 39.3g, and on-off total saponin as well as and content of the total saponins in radix notoginseng summation are 50.5%.
Embodiment 4:
The preparation of the total saponin extracts of Radix Dipsaci and Radix Notoginseng: with on-off total saponin as well as finished product 20g and Radix Notoginseng total arasaponins finished product 4g, add starch 76g, mix homogeneously, the back filled capsules or make tablet of granulating.
Embodiment 5:
The preparation of the total saponin extracts of Radix Dipsaci and Radix Notoginseng: with on-off total saponin as well as finished product 20g and Radix Notoginseng total arasaponins finished product 10g, add starch 70g, mix homogeneously, the back filled capsules or make tablet of granulating.
Embodiment 6:
The preparation of the total saponin extracts of Radix Dipsaci and Radix Notoginseng: with on-off total saponin as well as finished product 10g and Radix Notoginseng total arasaponins finished product 10g, add starch 80g, mix homogeneously, the back filled capsules or make tablet of granulating.
Embodiment 7:
The preparation of the total saponin extracts of Radix Dipsaci and Radix Notoginseng: with on-off total saponin as well as finished product 4g and Radix Notoginseng total arasaponins finished product 20g, add starch 76g, mix homogeneously, the back filled capsules or make tablet of granulating.
Embodiment 8:
The preparation of the total saponin extracts of Radix Dipsaci and Radix Notoginseng: with on-off total saponin as well as finished product 2g and Radix Notoginseng total arasaponins finished product 20g, add starch 78g, mix homogeneously, the back filled capsules or make tablet of granulating.
Embodiment 9:
The preparation of the total saponin extracts of Radix Dipsaci and Radix Notoginseng: with on-off total saponin as well as finished product 2g and Radix Notoginseng total arasaponins finished product 30g, add starch 68g, mix homogeneously, the back filled capsules or make tablet of granulating.
Embodiment 10:
The preparation of the total saponin extracts of Radix Dipsaci and Radix Notoginseng: press embodiment 3 prepared Radix Dipsacis and Radix Notoginseng total arasaponins finished product 25g, add starch 75g, mix homogeneously, the back filled capsules or make tablet of granulating.
Claims (4)
1. the active extract composition of Radix Dipsaci and Radix Notoginseng is characterized in that said composition is made up of on-off total saponin as well as and Radix Notoginseng total arasaponins, and its weight ratio is 1: 0.2～15.
2. the active extract composition of Radix Dipsaci according to claim 1 and Radix Notoginseng is characterized in that the optimum weight ratio of on-off total saponin as well as and Radix Notoginseng total arasaponins is 1: 0.5～5 in the said composition.
3. the application of the active extract composition of claim 1 or 2 described Radix Dipsacis and Radix Notoginseng in the medicine of preparation treatment fracture.
4. the application of the active extract composition of claim 1 or 2 described Radix Dipsacis and Radix Notoginseng in the osteoporotic medicine of preparation treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03112869 CN1209115C (en) | 2003-02-24 | 2003-02-24 | Active extracted composition of teasel root and notoginseng and use in medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03112869 CN1209115C (en) | 2003-02-24 | 2003-02-24 | Active extracted composition of teasel root and notoginseng and use in medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1433767A CN1433767A (en) | 2003-08-06 |
| CN1209115C true CN1209115C (en) | 2005-07-06 |
Family
ID=27634163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03112869 Expired - Fee Related CN1209115C (en) | 2003-02-24 | 2003-02-24 | Active extracted composition of teasel root and notoginseng and use in medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1209115C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100605116B1 (en) * | 2004-07-05 | 2006-07-31 | 주식회사 오스코텍 | Composition comprising Notoginseng Radix extract for preventing and treating of periodentitis as an effective component |
| CN102631420B (en) * | 2012-04-24 | 2013-09-18 | 吉林大学珠海学院 | Traditional Chinese medicine preparation capable of easing pain, diminishing inflammation and treating osteoporosis |
| CN107006765A (en) * | 2017-05-05 | 2017-08-04 | 泰山医学院 | A kind of preparation method for helping to move the Dietotherapy health congee of caused fracture and injury and the fast quick-recovery of soft tissue bruise |
| CN107982466A (en) * | 2017-12-27 | 2018-05-04 | 高永腾 | A kind of Chinese medicine composition for treating fracture and preparation method thereof |
-
2003
- 2003-02-24 CN CN 03112869 patent/CN1209115C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1433767A (en) | 2003-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102058673B (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
| US7081259B2 (en) | Herbal, extract having therapeutic activity on injuries, and pharmaceutical composition and health food containing the same | |
| CN1209115C (en) | Active extracted composition of teasel root and notoginseng and use in medicine | |
| CN1259955C (en) | Chinese medicine preparation for treating climacteric metancholia of women | |
| CN101485722B (en) | Medicament composition containing drynaria and salvia root, and use thereof | |
| CN114209764B (en) | Pharmaceutical composition, preparation and application for treating fracture | |
| CN1323588A (en) | New use of ginseng and ginseng stalk and leaf extractive in preventing and treating osteoposis | |
| CN105362382A (en) | Traditional Chinese medicine composition for treating recurrent oral ulcer and application thereof | |
| CN103028084A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method | |
| CN107007784A (en) | Chinese medicine composition for reversing A amyloid beta damaged nerve cells and preparation method and application | |
| CN1270740C (en) | Ready prepared Chinese medicine for treating angeitis and preparation process | |
| CN106880654B (en) | Application of panax japonicus extract in preparing medicine for treating rhinitis and composition | |
| CN100409892C (en) | Externally applied medicament for treating hyperplasia of mammary glands and preparation method thereof | |
| CN1931300A (en) | Externally applied medicine for treating women's dysmenorrhea | |
| CN117959361B (en) | Pharmaceutical composition for strengthening tendons and bones and preparation method thereof | |
| CN1879748A (en) | A group of compound Chinese medicinal oral preparation for treating osteoporosis and preparation method thererof | |
| CN115737729B (en) | Ethnic medicine preparation for treating osteoporosis and preparation method thereof | |
| CN1814122A (en) | Medicine for treating osteoporosis and preparing method | |
| CN116870076B (en) | Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof | |
| CN110215474B (en) | Traditional Chinese medicine composition for promoting blood circulation to remove blood stasis and application thereof | |
| CN116159098B (en) | Composition for preventing and treating degenerative osteoarthritis lesions | |
| CN1092968C (en) | Pharmaceuticals for treating outer skin blood vessel diease in cold seasons | |
| CN109718280B (en) | A Chinese medicinal composition for treating female climacteric syndrome, and its preparation method | |
| CN1205989C (en) | Medicine composition for treating ischemic necrosis of femur head and preparing process thereof | |
| CN1528415A (en) | Capsule for treating cervical spondylosis and hyperplastic arthritis and preparing process thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050706 |